Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adakveo
Pharma
EU regulators recommend pulling Novartis sickle cell med Adakveo
EU regulators have recommended revoking approval of Novartis' sickle cell med Adakveo after a phase 3 trial flop.
Zoey Becker
May 26, 2023 11:18am
EU officials taking closer look at Novartis' Adakveo after flop
Jan 30, 2023 1:15pm
NICE backs Novartis' Adakveo despite 'high uncertainty'
Oct 6, 2021 10:49am
Novartis, GBT anemia drugs face payer hurdles: survey
Jun 29, 2021 10:55am
Novartis taps celeb dancer for Adakveo social challenge campaign
Oct 21, 2020 3:15pm
Novartis trumpets Adakveo hospitalization data
Dec 8, 2019 6:00pm
